As shown by initial information from a South African trial that is currently undergoing critical analysis, the Omicron version significantly lowered immunogenicity created by the Pfizer-BioNTech COVID-19 vaccination.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>